134 related articles for article (PubMed ID: 22760710)
1. Pancreatic adenocarcinoma in young adults in a moroccan population.
Raissouni S; Rais G; Mrabti H; Raissouni F; Mouzount H; Aitelhaj M; El Khoyaali S; Mohtaram A; Errihani H
J Gastrointest Cancer; 2012 Dec; 43(4):607-11. PubMed ID: 22760710
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.
Duffy A; Capanu M; Allen P; Kurtz R; Olson SH; Ludwig E; Klimstra DS; O'Reilly EM
J Surg Oncol; 2009 Jul; 100(1):8-12. PubMed ID: 19384918
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.
Mokdad AA; Minter RM; Zhu H; Augustine MM; Porembka MR; Wang SC; Yopp AC; Mansour JC; Choti MA; Polanco PM
J Clin Oncol; 2017 Feb; 35(5):515-522. PubMed ID: 27621388
[TBL] [Abstract][Full Text] [Related]
4. Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort.
Pietrasz D; Marthey L; Wagner M; Blanc JF; Laurent C; Turrini O; Raoul JL; Terrebonne E; Hentic O; Trouilloud I; Coriat R; Regenet N; Innominato P; Taieb J; Cunha AS; Bachet JB
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1196-205. PubMed ID: 26271395
[TBL] [Abstract][Full Text] [Related]
5. Chemoradiotherapy after curative surgery for locally advanced pancreatic cancer: A 20-year single center experience.
Weibel P; Pavic M; Lombriser N; Gutknecht S; Weber M
Surg Oncol; 2021 Mar; 36():36-41. PubMed ID: 33285435
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
Cancer; 2010 Jun; 116(12):2932-40. PubMed ID: 20336787
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
[TBL] [Abstract][Full Text] [Related]
8. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
[TBL] [Abstract][Full Text] [Related]
9. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Nukui Y; Picozzi VJ; Traverso LW
Am J Surg; 2000 May; 179(5):367-71. PubMed ID: 10930481
[TBL] [Abstract][Full Text] [Related]
10. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.
Choi Y; Oh DY; Kim K; Chie EK; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Ha SW; Bang YJ
Cancer Res Treat; 2016 Jul; 48(3):1045-55. PubMed ID: 26511805
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
[TBL] [Abstract][Full Text] [Related]
14. How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort.
Pietrasz D; Turrini O; Vendrely V; Simon JM; Hentic O; Coriat R; Portales F; Le Roy B; Taieb J; Regenet N; Goere D; Artru P; Vaillant JC; Huguet F; Laurent C; Sauvanet A; Delpero JR; Bachet JB; Sa Cunha A
Ann Surg Oncol; 2019 Jan; 26(1):109-117. PubMed ID: 30362063
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer.
Morganti AG; Falconi M; van Stiphout RG; Mattiucci GC; Alfieri S; Calvo FA; Dubois JB; Fastner G; Herman JM; Maidment BW; Miller RC; Regine WF; Reni M; Sharma NK; Ippolito E; Valentini V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):911-7. PubMed ID: 25220717
[TBL] [Abstract][Full Text] [Related]
16. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
17. Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications.
Zhu X; Chen D; Cao Y; Zhao X; Ju X; Shen Y; Cao F; Qing S; Fang F; Jia Z; Zhang H
Cancer Biol Med; 2020 May; 17(2):492-500. PubMed ID: 32587784
[No Abstract] [Full Text] [Related]
18. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant
Hashmi A; Kozick Z; Fluck M; Hunsinger MA; Wild J; Arora TK; Shabahang MM; Blansfield JA
Am Surg; 2018 Sep; 84(9):1439-1445. PubMed ID: 30268172
[TBL] [Abstract][Full Text] [Related]
20. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]